Natera Price to Book Ratio 2014-2024 | NTRA
Historical price to book ratio values for Natera (NTRA) over the last 10 years. The current price to book ratio for Natera as of November 13, 2024 is 19.84.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Natera Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-12 | 135.12 | 19.09 | |
| 2024-09-30 | 126.95 | $7.08 | 17.94 |
| 2024-06-30 | 108.29 | $6.78 | 15.97 |
| 2024-03-31 | 91.46 | $6.50 | 14.08 |
| 2023-12-31 | 62.64 | $6.40 | 9.79 |
| 2023-09-30 | 44.25 | $6.59 | 6.71 |
| 2023-06-30 | 48.66 | $5.23 | 9.31 |
| 2023-03-31 | 55.52 | $5.74 | 9.67 |
| 2022-12-31 | 40.17 | $6.34 | 6.33 |
| 2022-09-30 | 43.82 | $3.72 | 11.79 |
| 2022-06-30 | 35.44 | $4.59 | 7.72 |
| 2022-03-31 | 40.68 | $5.63 | 7.22 |
| 2021-12-31 | 93.39 | $6.87 | 13.60 |
| 2021-09-30 | 111.44 | $8.03 | 13.88 |
| 2021-06-30 | 113.53 | $3.38 | 33.59 |
| 2021-03-31 | 101.54 | $4.26 | 23.84 |
| 2020-12-31 | 99.52 | $5.64 | 17.65 |
| 2020-09-30 | 72.24 | $6.29 | 11.49 |
| 2020-06-30 | 49.86 | $3.82 | 13.06 |
| 2020-03-31 | 29.86 | $3.29 | 9.07 |
| 2019-12-31 | 33.69 | $3.57 | 9.43 |
| 2019-09-30 | 32.80 | $1.20 | 27.44 |
| 2019-06-30 | 27.58 | $1.33 | 20.75 |
| 2019-03-31 | 20.62 | $0.08 | 262.01 |
| 2018-12-31 | 13.96 | $0.52 | 26.95 |
| 2018-09-30 | 23.94 | $0.92 | 26.10 |
| 2018-06-30 | 18.82 | $-0.40 | -47.36 |
| 2018-03-31 | 9.27 | $-0.07 | -129.83 |
| 2017-12-31 | 8.99 | $0.47 | 19.12 |
| 2017-09-30 | 12.89 | $0.56 | 22.94 |
| 2017-06-30 | 10.86 | $0.96 | 11.35 |
| 2017-03-31 | 8.87 | $1.40 | 6.36 |
| 2016-12-31 | 11.71 | $2.02 | 5.79 |
| 2016-09-30 | 11.11 | $2.68 | 4.15 |
| 2016-06-30 | 12.07 | $3.16 | 3.81 |
| 2016-03-31 | 9.52 | $3.54 | 2.69 |
| 2015-12-31 | 10.80 | $3.67 | 2.94 |
| 2015-09-30 | 10.85 | $4.13 | 2.63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.712B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $95.766B | 11.88 |
| Cencora (COR) | United States | $49.023B | 18.08 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| ICON (ICLR) | Ireland | $17.511B | 15.60 |
| Viatris (VTRS) | United States | $15.433B | 4.75 |
| Avantor (AVTR) | United States | $14.831B | 22.24 |
| Revvity (RVTY) | United States | $14.647B | 25.44 |
| BioMerieux (BMXMF) | France | $12.894B | 0.00 |
| CochLear (CHEOY) | Australia | $12.739B | 0.00 |
| Solventum (SOLV) | United States | $12.214B | 0.00 |
| Medpace Holdings (MEDP) | United States | $11.215B | 31.59 |
| Charles River Laboratories (CRL) | United States | $11.042B | 21.34 |
| Doximity (DOCS) | United States | $10.778B | 63.79 |
| HealthEquity (HQY) | United States | $8.750B | 47.49 |
| Sonic Healthcare (SKHHY) | Australia | $8.450B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.881B | 32.03 |
| Life Times (LTH) | United States | $5.005B | 33.12 |
| Sotera Health (SHC) | United States | $4.402B | 23.55 |
| Organon (OGN) | United States | $4.012B | 4.05 |
| Surgery Partners (SGRY) | United States | $3.759B | 42.85 |
| BrightSpring Health Services (BTSG) | United States | $3.402B | 72.37 |
| PACS (PACS) | United States | $3.129B | 0.00 |
| Concentras Parent (CON) | United States | $2.579B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.523B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.446B | 0.00 |
| Premier (PINC) | United States | $2.301B | 11.48 |
| GeneDx Holdings (WGS) | United States | $2.113B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.783B | 47.00 |
| Teladoc Health (TDOC) | United States | $1.670B | 0.00 |
| Progyny (PGNY) | United States | $1.551B | 29.62 |
| Pediatrix Medical (MD) | United States | $1.331B | 13.02 |
| CareDx (CDNA) | United States | $1.251B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.993B | 6.72 |
| Embecta (EMBC) | United States | $0.898B | 5.99 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| InnovAge Holding (INNV) | United States | $0.778B | 0.00 |
| Agilon Health (AGL) | United States | $0.770B | 0.00 |
| SBC Medicals (SBC) | United States | $0.717B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.510B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.442B | 0.00 |
| DocGo (DCGO) | United States | $0.426B | 16.00 |
| Enhabit (EHAB) | United States | $0.383B | 33.09 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.346B | 0.00 |
| LifeMD (LFMD) | United States | $0.310B | 0.00 |
| ModivCare (MODV) | United States | $0.244B | 13.24 |
| Sera Prognostics (SERA) | United States | $0.242B | 0.00 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Nutex Health (NUTX) | United States | $0.204B | 0.00 |
| Biodesix (BDSX) | United States | $0.204B | 0.00 |
| MultiPlan (MPLN) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.120B | 0.00 |
| So-Young (SY) | China | $0.073B | 17.77 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.12 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |